Juul's Next-Generation Vaporizer Seeks FDA Approval Amid Market Uncertainty
Portfolio Pulse from Vandana Singh
Juul Labs Inc is seeking FDA approval for its next-generation vaporizer, which is already available in the U.K. and Canada. The new device has age-verification features and prevents the use of unauthorized refill cartridges. Earlier this year, Altria Group Inc (NYSE:MO) divested Juul Labs, recording a loss of at least $12.5 billion. Juul Labs is also researching additional flavors like menthol and taking steps to prevent underage access.

July 20, 2023 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Altria Group Inc (NYSE:MO) divested Juul Labs earlier this year, recording a loss of at least $12.5 billion. The company's future financial performance could be impacted by the FDA's decision on Juul's new product.
Altria Group's divestment from Juul Labs resulted in a significant financial loss. The FDA's decision on Juul's new product could further impact Altria's financial performance, either positively if the product is approved and successful, or negatively if it is not approved or fails to gain market traction.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 75